Trial intelligence / Profile preview

RIAA: Rosuvastatin for Lipid Targets in African Americans With Stroke/TIA

NCT01975194Phase 4Terminated

Sponsor
Wayne State University
Start
Jan 2012
Primary completion
Aug 2013
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in hypercholesterolemia, sponsored by Wayne State University. Started Jan 2012; status: terminated.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01975194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01975194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call